Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3Phase NA 1Phase 4 1Phase 3 1Phase 1/2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 1Glioma 1Carcinoma, Medullary 1Brain Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Lithium Carbonate × Clear all
NCT05402891 2024-10-04

Lithium in FAP

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed
12 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT00582712 2019-12-09

An Initial Study of Lithium in Patients With Medullary Thyroid Cancer

University of Wisconsin, Madison

Phase 2 Terminated
5 enrolled 7 charts

Carcinoma, Medullary

NCT00501540 2019-11-26

Lithium for Low-Grade Neuroendocrine Tumors

University of Wisconsin, Madison

Phase 2 Completed
15 enrolled 10 charts
EndocrineNET

Neuroendocrine Tumors

NCT01105702 2016-08-04

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

NYU Langone Health

Phase 2 Terminated
28 enrolled 9 charts
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡